To enhance the implementation of China’s Cosmetics Supervision and Administration Regulations and promote ingredient innovation, the National Medical Products Administration (NMPA) has released Announcement No. 61 of 2025. This update introduces a dynamic adjustment mechanism for the Inventory of Existing Cosmetic Ingredients (IECIC) – enabling continuous updates, improved accuracy, and better alignment with global cosmetic safety practices. The move marks a major step toward more transparent and science-driven cosmetic ingredient management in China. To clarify key management issues related to the IECIC, the NMPA has issued a series of official responses. The cosmetic team at CIRS Group has compiled and translated these explanations for industry reference.
